Clinical Trial Update: Patient Convenience Study

View source ↗

Summary

A Boehringer Ingelheim-sponsored patient convenience study in atrial fibrillation has completed, with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Atrial Fibrillation | Status: COMPLETED | Results posted: 2019-02-21